by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min As US drug pricing negotiations are making headlines every day, our analysis found that pharma’s reputation is suffering mainly because of media misconceptions that companies can clear out. What we found: Our study of 1,705 English-language...
by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min While Wegovy reshaped public attitudes about obesity, its maker Novo Nordisk oversaw critical reputational threats, highlighting that product success alone cannot safeguard pharma companies without a comprehensive, data-driven reputation management...
by Commetric | Jan 22, 2024 | Blog
CEOs are increasingly called upon to address the impacts of innovation not only within their businesses but also in society at large. This was one of the main findings of Edelman’s Trust Barometer, which was released for the World Economic Forum in Davos this...
by Commetric | Jan 14, 2024 | Blog
The J.P. Morgan Healthcare Conference, the most anticipated event in the biotech and pharma calendars, has a reputation for drawing major announcements from big players in the industry. The 2024 edition has not disappointed. Analysing 289 English-language articles...
by Commetric | Jan 3, 2024 | Blog
At Commetric, we’re in the habit of turning to data to answer any question. So, when we wanted to look at the most prominent PR trends in 2023, we decided to check which of our analyses received the most attention from our readers – who are predominantly...
